The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are pro
-
Page/Page column 19
(2009/12/05)
7-Trans-(2-pyridylethenyl)-5H-thiazolo[3,2-a]pyrimidine-5- ones: Synthesis and pharmacological activity